| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease | |
| | GLA, RPL36A-HNRNPH2 (A368P +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (A368T +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not specified +2 more | |
| | GLA, RPL36A-HNRNPH2 (D299E +1 more) | Single nucleotide variant (missense variant +2 more) | not provided | |
| | GLA, RPL36A-HNRNPH2 (I289V +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (R268Q) | Single nucleotide variant (missense variant +2 more) | not provided +1 more | |
| | GLA, RPL36A-HNRNPH2 (N215S +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiomyopathy +4 more | |
| | | Single nucleotide variant (intron variant) | not specified +2 more | |
| | GLA, RPL36A-HNRNPH2 (A143T +1 more) | Single nucleotide variant (missense variant +2 more) | Primary familial hypertrophic cardiomyopathy +5 more | GConflicting classifications of pathogenicity |
| | RPL36A-HNRNPH2, GLA (R118C +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +4 more | GConflicting classifications of pathogenicity |
| | GLA, HNRNPH2 +1 more (R112H +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | not specified +4 more | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | Fabry disease +3 more | |
| | | Single nucleotide variant (intron variant) | Fabry disease +2 more | |